Lucas W

Carhart-Harris Lab, University of California San Francisco, San Francisco, CA, USA.

2 preprints · 2 papers · ORCID

PreprintPsilocybin

Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases

Sarvi M, Lucas W, Levander X +1

Europe PMC2026
ArticlePsychedelics

Well-being as a primary endpoint in clinical trials: a call for consensus.

Marseille E, Kettner H, Sgambati TJ +6

Europe PMC2026
ArticlePsilocybin

Mindset over molecule: comparing self-transcendent and mystical experiences across recreational psilocybin, MDMA, and cannabis use.

Chwyl C, Spata A, Lucas W +1

Europe PMC2026
PreprintPsilocybin

Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use

Chwyl C, Spata A, Lucas W +1

Europe PMC2025